Dechra Pharmaceuticals Share Price (DPH)

1,269.00 +13.00 (+1.04%) delayed: 9:56PM BST
Bid price 1,269.00 Open price 1,258.00
Ask price 1,274.00 Prev close 1,269.00
High price 1,274.00 Spread 0.39%
Low price 1,250.00 Volume 69,579

Register now for FREE live Dechra Pharmaceuticals share prices, Dechra Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Dechra Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Dechra Pharmaceuticals (DPH) and other London Stock Exchange equities.

Dechra Pharmaceuticals Share Price Chart

Advanced Charts >>

Register now for FREE Dechra Pharmaceuticals share price charts

Dechra Pharmaceuticals Share Price Information

Name Dechra Pharmaceuticals Epic DPH
Sector Pharmaceuticals & Biotechnology ISIN GB0009633180
Activites Dechra Pharmaceuticals plc is an international veterinary pharmaceutical business. Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. Index FTSE 250

Dechra Pharmaceuticals Key Numbers

Latest Share Price (p) 1,269.00 Net Gearing (%) 17.70
Market Capitalisation (£m) 1,162.06 Gross Gearing (%) 33.42
Shares in issue (m) 92.71 Debt Ratio 21.58
P/E Ratio 56.62 Debt-to-Equity Ratio 0.55
Total dividends per share (p) 16.94 Assets / Equity Ratio 1.50
Dividend Yield (%) 1.39 Price to book value 5.97
Dividend cover (x) 1.25 ROCE (%) 10.41
Earning per share (p) 22.14 EPS Growth (%) -67.23
52 week high / low 1,273.00 / 811.00 DPS Growth (%) 10.00

Dechra Pharmaceuticals Director Deals

Dec.Date Type Director Pos No. of Shares
06/06/2016 BUY Tony Rice NED 20,000
18/03/2016 EXR Ian Page CEO 87,905
18/03/2016 SEXR Ian Page CEO 41,440
18/03/2016 EXR Tony Griffin ED 32,027
09/09/2015 EXR Anne-Françoise Nesmes FD 38,859

More Dechra Pharmaceuticals Director Deals >>

Dechra Pharmaceuticals Company News

16:52 12/07/2016

Stronger pound boosts FTSE 250

A stronger pound versus the euro saw the internationally focused FTSE 100 fall flat but was a boon for the domestically biased FTSE 250, up by 0.4% to 16,780.09. Lucky Strike owner British American Tobacco (BATS) retreated 1.7% to 4,836.5p, contributing to negative momentum in the FTSE 100....

15:00 12/07/2016

Broker Forecast - Numis issues a broker note on Dechra Pharmaceuticals PLC

Numis today reaffirms its add investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and set its price target at 1320p. Story provided by

12:02 12/07/2016

FTSE 250 races ahead of May's start as Prime Minister

UK companies continued to bloom as the FTSE 250 advanced towards the 17,000 mark after Theresa May was announced as the new Prime Minister from 13 July. The FTSE 100 slid 0.08% to 6,677.18, while the FTSE 250 climbed 0.8% to 16,836.99. Investors were comforted by the new premier as May is seen...

More Dechra Pharmaceuticals Company News >>

Register now for FREE Dechra Pharmaceuticals company news

Dechra Pharmaceuticals Share Price Discussions

more than 1 year ago

A really dreary share (DPH)

A really dreary share! Dechra Pharmaceuticals manufactures and distributes vetinary products and equiptment.Has a few own brands:- Equipalazone,Vetoryl and Felimazole -anyone used them? My stockbroker molested me so much over this company that I finally bought at 130p,(Feb 04); now at 182.5p...

Register now for FREE Dechra Pharmaceuticals share price discussions